Skip to main content
SpringerLink
Log in

Dopaminergic therapy first choice in patients with restless legs syndrome

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Milligan SA, Chesson AL. Restless legs syndrome in the older adult: diagnosis and management. Drugs Aging 2002; 19(10): 741–51

    Article  PubMed  CAS  Google Scholar 

  2. Walters AS. Towards a better definition of the restless legs syndrome. Mov Disord 1995; 5: 634–42

    Article  Google Scholar 

  3. Trenkwalder C, Walters AS, Hening W. Periodic limb movements and restless leg syndrome. Neurol Clin 1996; 14: 629–50

    Article  PubMed  CAS  Google Scholar 

  4. Montplaisir J, Nicolas A, Godbout R, et al. Restless legs syndrome and periodic limb movement disorder. In: Kryger MH Roth T, Dement WC, editors. Principles and practice of sleep medicine. 3rd ed. Philadelphia (PA): WB Saunders, 2000: 742–52

  5. Walters AS, Hickey K, Maltzman J, et al. A questionnaire study of 138 patients with restless legs syndrome: the nightwalkers survey. Neurology 1996; 46: 92–5

    Article  PubMed  CAS  Google Scholar 

  6. Sun ER, Chen CA, Ho G, et al. Iron and the restless legs syndrome. Sleep 1998; 21: 371–7

    PubMed  CAS  Google Scholar 

  7. Allen RP, Earley CJ. Validation of the Johns Hopkins Restless Legs Severity Scale. Sleep Med 2001; 2: 239–42

    Article  PubMed  Google Scholar 

  8. Chesson AL, Wise M, Davila D, et al. Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999; 22: 961–8

    PubMed  Google Scholar 

  9. Henning W, Allen R, Earley C, et al. The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 1999; 22: 970–99

    Google Scholar 

  10. Henning WA. Restless legs syndrome. Curr Treat Options Neurol 1999; 1: 309–19

    Article  Google Scholar 

  11. O’Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23: 200–3

    Article  PubMed  Google Scholar 

  12. British National Formulary. No. 42. London: The Pharmaceutical Press, 2002 Sep

  13. Weimerskirch PR, Ernst ME. Newer dopamine agonists in the treatment of restless legs syndrome. Ann Pharmacother 2001; 35: 627–30

    Article  PubMed  CAS  Google Scholar 

  14. Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999; 52: 1908–10

    Article  PubMed  CAS  Google Scholar 

  15. Olanow CW, Schapira AHV, Roth T. Waking up to sleep episodes in Parkinson’s disease. Mov Disord 2000; 15: 212–5

    Article  PubMed  CAS  Google Scholar 

  16. Happe S, Klosch G, Saletu B, et al. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 2001; 57: 1717–9

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dopaminergic therapy first choice in patients with restless legs syndrome. Drugs Ther. Perspect 19, 10–13 (2003). https://doi.org/10.2165/00042310-200319060-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200319060-00004

Keywords

Search

Navigation